Disclosures Dr. Klein’s clinical and research interests cover all stages of prostate cancer with a focus on genomics and clinical trials. Under his direction, the Prostate Cancer Research Program has been recognized as “Program of the Year” by the Cleveland Clinic. He has served as Chairman of the Localized Prostate Cancer Committee of the Southwest Oncology Group and was the National Study Coordinator for the NCI-sponsored Selenium and Vitamin E Cancer Prevention Trial (SELECT). Dr. Klein has contributed more than 700 papers to the scientific literature, authored or edited 8 books on urologic malignancies, and serves as the Editor-in-Chief of UROLOGY. He has delivered more than 200 invited scientific lectures including 13 named lectureships and has served as a Visiting Professor at more than 60 institutions around the world. Dr. Klein was awarded the F. Mason Sones Innovation Award by the Cleveland Clinic in 2009, The Joe V. Meigs Award by the Society of Pelvic Surgeons in 2013 and 2015, was named the Kidney Foundation of Ohio’s Person of the Year in 2017, and has received 6 Career Achievement Awards including the 2001 Norman K. Probstein Award for Meritorious Contributions to Oncology from the Washington University School of Medicine, a 2014 Presidential Citation from the American Urological Association, the 2014 Huggins Medal from the Society of Urologic Oncology, the 2015 Philip S. Hench Award from the University of Pittsburgh School of Medicine, the 2020 SUO Medal from the Society of Urologic Oncology, and the 2020 Richard D. Williams, MD Prostate Cancer Research Excellence Award from the Urology Care Foundation.